Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Evan Loh currently holds 258,750 shares of Paratek Pharmaceuticals, Inc. (PRTK), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Evan Loh has been a net seller of PRTK stock. They have purchased $98.6K and sold $2.6M worth of shares.
Evan Loh's most recent insider trade was on Sep 21, 2023, when they sold 1,069,231 shares at $0.00 per share.
Evan Loh serves as Executive at Paratek Pharmaceuticals, Inc. (PRTK). They have executed 59 insider transactions totaling $2.7M over their tenure at the company.
Evan Loh holds the position of Executive at Paratek Pharmaceuticals, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 11 years and currently hold a stake valued at $0.
Evan Loh has shown a selling trading pattern, with $98.6K in total purchases and $2.6M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Evan Loh was on Jun 4, 2021, when they sold $355.5K worth of PRTK shares. This transaction involved 36,654 shares at $9.70 per share.
Evan Loh currently owns 258,750 shares of Paratek Pharmaceuticals, Inc. (PRTK), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Evan Loh's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Evan Loh has 59 Form 4 filings on record as an insider at Paratek Pharmaceuticals, Inc..
Set alerts for Evan Loh and 40,000+ other insiders.